Summary
In the literature there is no agreement on the prevalence of chronic liver disease (CLD) and the role of hepatitis B virus (HBV) infection in diabetics. We undertook an epidemiological case-control study of the prevalence of CLD and HBV infection in 394 diabetics and 265 healthy subjects from Seriate and Como. The results did not show any significant differences between: 1) the prevalence of CLD in the diabetic population and in controls (4.8%vs 4.5%); 2) the prevalence of HBV infection in diabetics (HBsAg+: 8.3%: HBVAb+: 55.8%) and in controls (HBsAg+: 8.6%; HBVAb+: 54.7%); 3) the prevalence of HBV infection in diabetics with CLD (HBsAg+: 21%; HBVAb+: 52.6%) and in controls with CLD (HBsAg+: 16.6%; HBVAb+: 50%); 4) the prevalence of HBV infection in diabetics with and without CLD (HBsAg+: 21%vs 7.7%; HBVAb+: 52.6%vs 56%); 5) the prevalence of HBV infection in diabetics treated by injection and orally (HBsAg+: 6.9%vs 8.6%; HBVAb+: 58.3%vs 55.2%). The relative risk of CLD for the factor HBsAg+ was 3.2 in the diabetic populationvs 1.4 in controls. In view of the presence of antidelta antibodies (HDVAb) in 25% of HBsAg+ diabetics with CLD and the lack of HBV markers in 26.3% of diabetics with CLD, we assume that other viruses (Delta, nonA-nonB) may play roles. Probably the interaction of all possible etiopathogenetic factors (alcohol, viruses, glycometabolic derangement) is determinant for CLD in diabetics.
Similar content being viewed by others
References
Bedarida G., D’Agostino F., Bianchi M., Susani G., Sangalli F., Fattorini A., Sterza G.: Unexpected lower prevalence of HBsAg in diabetics than in controls — La Ricerca Clin. Lab.12, 409, 1982.
Bergmeyer H. U., Bern E.: Glutamate-oxaloacetate transaminase. In:Bergmeyer H. U. (Ed.): Methods in enzymatic analysis. Academic Press, New York, 1963; p. 837.
Bettale G., Colloredo Mels G., Bellati G., Granata S., Colombo A., Agazzi C., Perin S., Tanzi E., Angeli G., Idéo G.: Ruolo dell’infezione con il virus B(HBV) e con l’agente delta (HDV) nell’epatopatia cronica del diabete mellito. Abstract of the 5th Symposium on Australia Antigen, Castrocaro, 1984; p. 69.
Biggs R., MacFarlane R. G.: Human blood coagulation and its disorders. Blackwell Sci. Publication, Oxford, 1962.
Creutzfeldt W.: Morphologische Befunde an der Leber von Diabetikern nach langfristiger Sulfonylharnstoffbehandlung und an verschiedenen Organen nach Synthalin- und DBI-Vergiftung beim Tier. In:Oberdisse K., Jahnke K. (Eds): Diabetes mellitus. Kongr. Internat. Diab. Fed. Düsseldorf, 21.–25. Juli 1958. Georg Thieme Verlag, Stuttgart 1959; p. 267.
Davis J. E., McDonald J. M., Jarrett L.: A high-performance liquid chromatography method for hemoglobin A1c — Diabetes27, 102, 1978.
Frankel J. J., Asburg C. E., Baker L. A.: Hepatic insufficiency and cirrhosis in diabetes mellitus — A.M.A. Arch. intern. Med.86, 376, 1950.
Henry R. J.: Clinical chemistry. Principles and technics. 2nd ed. Harper and Row Publishers Inc., Hagerstown/MD, 1974; p. 917.
Horiuchi N., Sasaki A., Hasegawa K., Uehara M.: A study of diabetic fatalities due to liver cirrhosis. 11th Congress of the International Diabetes Federation Nairobi, 1982. Excerpta Medica, Amsterdam-Oxford-Princeton, 1982; p. 236, abstract # P 164.
International Group: Acute and chronic hepatitis revisited — Lancetii, 914, 1977.
Jaques W. E.: The incidence of portal cirrhosis and fatty metamorphosis in patients dying with diabetes mellitus — New Engl. J. Med.249, 442, 1953.
Jendrassik L.: Vereinfachte photometrische Methoden zur Bestimmung — Biochem. Z.297, 81, 1938.
Joslin E. P., Root H. P., White P., Marble A. (Eds): The treatment of diabetes mellitus, 10 Ed. Lea and Febiger, Philadelphia, 1959.
Kachmar J. F., Moss D. W.: Fundamentals of clinical chemistry. W.B. Saunders, Philadelphia, 1976; p. 602.
Kaito I.: Studies on the coincidence of diabetes mellitus with gallbladder, duct and liver diseases in Japan — Tohoku J. exp. Med.51, 261, 1949.
Khuri K. G., Shamma’a M. H., Abourizk N.: Hepatitis B virus markers in diabetes mellitus — Diabetes Care8, 250, 1985.
Lohr K., Reinwein H.: Konkordantes Auftreten von Leberzirrhose und Diabetes mellitus (Hämochromatose) bei eineiigen Zwillingen — Dtsch. Arch. klin. Med.200, 53, 1952.
MacDonald T. A., Mallory G. K.: The natural history of postnecrotic cirrhosis — Amer. J. Med.24, 334, 1958.
Madaliński K., Brozsko W. L., Malczewski B., Czyżyk A.: Au/H.A.A. in sera of diabetic patients — Lanceti, 701, 1971.
Marigo S., Bernardi F., Coli A., Canova G., Faccini G., Russo R.: Australia antigen in diabetic subjects — Acta diabetol. lat.13, 93, 1976.
Meluzín F., Kubeová F., Špička J., Slavík V.: Frekvence Australia antigenu (HBsAg) u zdravotnických procavnikú a diabetikú — Čas. Lék. čes.113, 1387, 1974.
Metropolitan Life Insurance Company: Statistical Bulletin n. 41, 1960.
Mincu I., Ionescu-Tirgoviste C., Popa E., Budu M., Cheta D., Bruckner I., Boboia D.: The frequency and characteristics of liver diseases in diabetics. Clinical and biological study in 4600 cases and histological study of 311 cases. In.:Bajaj J. S. (Ed.) Current topics in diabetes research. Abstracts, IX Congress of the International Diabetes Federation, New Delhi, 1976. Excerpta Medica, Amsterdam-Oxford, 1976; p. 68, abstract # 136.
Müting D., Lackas N., Reikowski H., Richmond S.: Leberzirrhose und Diabetes mellitus — Dtsch. med. Wschr.91, 1433, 1966.
National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance — Diabetes28, 1039, 1979.
Overby L. R., Ling C. M.: Radioimmunoassay for anti-core as evidence for exposure to hepatitis B virus — Rush-Presbyterian St. Luke’s med. Bull.15, 83, 1976.
Poche R., Schumacher K. T.: Über Zusammenhänge zwischen Diabetes mellitus und Leberzirrhose — Dtsch. Z. Verdau. Stoffweschselkr.16, 68, 1956.
Rathore L. S., Tiwari A. K., Khanijo S. K.: Liver and diabetes. In:Bajaj J. S. (Ed.): Current topics in diabetes research. Abstracts, IX Congress of the International Diabetes Federation, New Delhi, 1976. Excerpta Medica, Amsterdam-Oxford, 1976; p. 69, abstract # 137.
Regli A.: Kombinationsformen von Laennec’scher Leberzirrhose mit Diabetes mellitus: ihre Beziehungen zur Hämochromatose — Helv. med. Acta21, 535, 1954.
Reinberg M. H., Lipson M.: The association of Laennec’s cirrhosis with diabetes mellitus — Ann. intern. Med.33, 1195, 1950.
Robbers H., Stohfeldt P., Kruger C.: Differentialdiagnose der diabetischen und alkoholischen Fettleber. Untersuchungen an 171 Diabetikern un 100 Patienten mit Alkoholabusus — Dtsch. med. Wschr.93, 112, 1968.
Savagnone E., Caruso V., Mondello P., Patti S., Spicola L., Spanò C.: Hepatitis B virus in diabetic patients — Acta diabetol. lat.17, 207, 1980.
Schleusner V.: Über die Zusammenhänge zwischen Diabetes mellitus und Erkrankungen der Leber und der Gallenwege. Dissertation, Hamburg, 1938.
Seige K., Thierbach V.: Posthepatitische Schäden bei Diabetes mellitus — Verh. dtsch. Ges. inn. Med.65, 705, 1959.
Szasz G.: A kinetic photometric method for serum gamma GT — Clin. Chem.15, 124, 1969.
Trinder P.: Determination of glucose in blood using glucose oxydase with an alternative oxygen acceptor — Ann. clin. Biochem.6, 24, 1969.
Walsh J., Yalow R., Berson S.: Determination of Australia antigen and antibody by means of radioimmunoassay techniques — J. infect. Dis.121, 550, 1970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mels, G.C., Bettale, G., Bellati, G. et al. Role of hepatitis B virus infection in chronic liver disease of diabetic patients: A case-control study. Acta diabet. lat 23, 29–34 (1986). https://doi.org/10.1007/BF02581351
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581351